ACELYRIN, INC., Affibody AB, and Inmagene Bio Announce Positive Results from Global Phase 2 Trial of Izokibep in Patients with Psoriatic Arthritis
Top range efficacy for ACR and PASI scoresProportion of patients with resolution of enthesitis appears differentiatingSupports hypothesis that izo...
Source: businessinsider.com